Form 4: Vericel Corp Executive Jonathan Hopper Executes Stock Option and Sells Shares

Chief Medical Officer Jonathan Hopper exercised stock options and sold 10,000 shares of Vericel Corp stock on May 20, 2024, according to a Form 4 filing.

Summary

• On May 20, 2024, Jonathan Mark Hopper, Chief Medical Officer of Vericel Corp, exercised stock options to acquire 10,000 shares of common stock at a price of $10.95 per share.
• Simultaneously, Hopper sold 10,000 shares of Vericel Corp common stock at a price of $49.99 per share.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 17, 2023.
• Following these transactions, Hopper directly owns 58,116 shares of Vericel Corp common stock.
• Hopper also holds options to purchase 22,604 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions. The use of a 10b5-1 plan suggests pre-planned activity, reducing potential negative interpretations.

Industry Context

Executive stock transactions are common and are often scrutinized by investors for insights into a company's prospects. Rule 10b5-1 plans allow insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders as they reflect insider activity, but the pre-planned nature mitigates concerns.

Key Dates